SCHEMBL28335461

SCHEMBL28335461

Cc1ncnn1-c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.54
CYP2E1 P05181 2/20 0.54
CYP3A4 P08684 2/20 0.54
GRM1 Q13255 4/20 0.43
CYP11B2 P19099 1/20 0.42
AR P10275 1/20 0.41
ALOX12 P18054 1/20 0.40
PI4KA P42356 1/20 0.39
PI4K2B Q8TCG2 1/20 0.39
PI4K2A Q9BTU6 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ELANE P08246 1/20 0.38
PIK3CD O00329 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10166462 0.79 MAPK1 (0.41) PI4KAPI4K2BPI4K2API4KBHTT
SCHEMBL17457925 0.79 CYP2A6 (0.47) CYP2A6CYP2E1CYP3A4GRM1CYP11B2
SCHEMBL2691172 0.74 CYP2A6 (0.49) CYP2A6CYP2E1CYP3A4GRM1CYP11B2
Hydrochloric Acid SCHEMBL25406612 0.73 CYP2A6 (0.42) CYP2A6CYP2E1CYP3A4CYP11B2PI4KA
SCHEMBL25078673 0.73 NPC1 (0.50) CYP3A4HTTALDH1A1L3MBTL1
SCHEMBL24774169 0.71 PCSK9 (0.41) HTTALDH1A1
SCHEMBL24185394 0.71 POLB (0.46) L3MBTL1
SCHEMBL26643954 0.71 NOS3 (0.44) HTTPIK3CD
SCHEMBL28538769 0.71 P2RX7 (0.50) CYP2A6CYP11B2ALDH1A1L3MBTL1
SCHEMBL15723543 0.71 XDH (0.45) CYP3A4HTTALDH1A1L3MBTL1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107501274-B It can be used as the compound of ATR kinase inhibitor Votex Pharmaceutical Co., Ltd. (US) 2019-11-22 CN disclosed
CN-107501275-B It can be used as the compound of ATR kinase inhibitor Votex Pharmaceutical Co., Ltd. (US) 2019-11-22 CN disclosed